TCG Crossover Management »

Athira Pharma shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Athira Pharma shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3M 464k 7.21

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cogent Biosciences Comm (COGT)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Centessa Pharmaceuticals Adrs (CNTA)
Dyne Therapeutics Comm (DYN)
Rapt Therapeutics Comm (RAPT)
Tyra Biosciences Comm (TYRA)
Amylyx Pharmaceuticals Comm (AMLX)
Savara Comm (SVRA)
Monte Rosa Therapeutics Comm (GLUE)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Eyepoint Pharmaceuticals Comm (EYPT)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Athira Pharma

Perceptive Advisors
TCG Crossover Management
Commodore Capital
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors
Geode Capital Management
Susquehanna International

View all funds holding Athira Pharma